Sign in
CompletedPhase 4

Two-level ESPB in Total Knee Arthroplasty

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
60 people enrolled
Started
7 Nov 2024
Ended
5 Aug 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 2 x 20 ml of Ropivacaine 0.2% Injectable Solution
  • 2 x 20ml of Ropivacaine 0.2% Injectable Solution
Record updated
25 November 2025

Who can take part

Age
65 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • patients scheduled for total hip arthroplasty
  • patients aged >65 and <100 years
  • patients able to provide informed consent
  • patients able to reliably report symptoms to the research team

Who cannot take part

  • inability to provide first-party consent due to cognitive impairment or a language barrier

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Effect of two-level ESPB in Total Knee Arthroplasty

The 2 groups in the trial

  • iPACK + ACBExisting treatment, for comparison

    Ultrasound-guided iPACK +ACB

    Treatment: 2 x 20 ml of Ropivacaine 0.2% Injectable Solution

  • Two-Level ESPBExisting treatment, for comparison

    Bi-level Ultrasound-guided ESPB et the L1 and S1

    Treatment: 2 x 20ml of Ropivacaine 0.2% Injectable Solution

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Two-level Erector Spinae vs iPack With ACB Plane Block in Total Knee Arthroplasty
Record updated
25 November 2025